Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
cbdMD (YCBD)
NYSE MKT:YCBD
Holding YCBD?
Track your performance easily
YCBD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $1.73
Previous Close$0.58
Volume29.22K
Average Volume (3M)127.34K
Market Cap
$2.25M
Enterprise Value$4.11M
Total Cash (Recent Filing)$1.50M
Total Debt (Recent Filing)$3.37M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 14, 2024EPS Estimate
-$0.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.89
Shares Outstanding3,869,082
10 Day Avg. Volume34,646
30 Day Avg. Volume127,342
Standard Deviation0.28
R-Squared0.14
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.34
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.17
Enterprise Value/Gross Profit0.18
Enterprise Value/Ebitda-0.73
Forecast
1Y Price Target
$2.00Price Target Upside236.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
cbdMD News
PremiumCompany Announcements
cbdMD Expands Board with CEO T. Ronan Kennedy
PremiumPre-Earnings
Is YCBD a Buy, Before Earnings?
PremiumPre-Earnings
Cbdmd INc (YCBD) Q2 Earnings Cheat Sheet
PremiumCompany Announcements
cbdMD Announces Executive Changes and Shareholder Vote Outcomes
PremiumCompany Announcements
cbdMD Executives to Present at Upcoming Investor Road Shows
Bulls Say, Bears Say
Bulls Say
Brand ExpansionThe launch of ATRx Labs and HempMD brands onto Amazon.com and upcoming retail expansion suggest potential for topline growth.
Market GrowthAccording to Grand View Research, the global cannabidiol (CBD) market is expected to expand at a compounded annual growth rate (CAGR) of 16.2% between 2023 and 2030.
Operational EfficiencyRecently, the company enacted several initiatives to reduce costs and drive operational efficiencies, which included reducing SKU count from 190 to approximately 60, and migrating its e-commerce sites to Shopify's platform.
Bears Say
Corporate StructureA proposed amendment to convert Series A preferred stock into common stock is seen as a pivotal move for the company's capacity to secure future funding.
Earnings ReportCbdMD reported revenue below estimates, leading to lowered future revenue projections and price target adjustments.
Regulatory ChallengesThe regulatory landscape for CBD products is currently fraught with uncertainty and instability, with no foreseeable guidance from the FDA.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
YCBD FAQ
What was cbdMD’s price range in the past 12 months?
cbdMD lowest stock price was $0.55 and its highest was $1.73 in the past 12 months.
What is cbdMD’s market cap?
Currently, no data Available
When is cbdMD’s upcoming earnings report date?
cbdMD’s upcoming earnings report date is Aug 14, 2024 which is 131 days ago.
How were cbdMD’s earnings last quarter?
cbdMD released its earnings results on May 15, 2024. The company reported -$1.35 earnings per share for the quarter, missing the consensus estimate of -$0.75 by -$0.6.
Is cbdMD overvalued?
According to Wall Street analysts cbdMD’s price is currently Undervalued.
Does cbdMD pay dividends?
cbdMD does not currently pay dividends.
What is cbdMD’s EPS estimate?
cbdMD’s EPS estimate is -$0.62.
How many shares outstanding does cbdMD have?
cbdMD has 3,869,082 shares outstanding.
What happened to cbdMD’s price movement after its last earnings report?
cbdMD reported an EPS of -$1.35 in its last earnings report, missing expectations of -$0.75. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of cbdMD?
Currently, no hedge funds are holding shares in YCBD
---
cbdMD Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (236.93% Upside)
$2.00 (236.93% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 11.6%
Last 30 Days ▲ 11.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.96%
12-Months-Change
Fundamentals
Return on Equity
-149.98%
Trailing 12-Months
Asset Growth
-56.80%
Trailing 12-Months
Company Description
cbdMD
cbdMD, Inc. is a nationally recognized consumer cannabidiol brand which engages in producing and distributing of CBD products. Its products include CBD tinctures, CBD gummies, CBD topical, CBD bath bombs, and CBD pet products. cbdMD was founded by Caryn Dunayer in March 2015 and is headquartered in Charlotte, NC.
---
YCBD Earnings Call
Q1 2024
0:00 / 0:00
---
YCBD Stock 12 Month Forecast
Average Price Target
$2.00
▲(236.93% Upside)
Technical Analysis
Best Analysts Covering YCBD
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-23.88%
reiterated a buy rating 7 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -23.88% per trade.
---